Irish TDs Urge Pharma Company and HSE to Provide Access to Skyclarys Drug

Irish TDs are calling on a pharmaceutical company to collaborate with the HSE to make the life-changing drug Skyclarys available, despite its high annual cost of €288,000 per patient.